Cardiology

A recent analysis that included data on 284 patients found that more than 80% of patients with resistant hypertension also had obstructive sleep apnea.

Through clinical trials, investigators find that SGLT2 inhibitors are not only safe, but have several cardiovascular benefits.

The scope and scale of kidney disease is on the rise—much like its most commonly associated conditions.

A recent study found the lifetime risk of peripheral artery disease in black patients was around 30% while Hispanic and white patients had prevalence rates around 20%.

A recent study from investigators at the Rutgers Robert Wood Medical School found that rates of hypertension among pregnant women have spiked between 1970 and 2010.

A study from the University of California San Francisco found that patients with HIV were at an 80% increased risk of suffering from atrial fibrillation.

Dhruv Kazi, MD, of Beth Israel Deaconess Medical Center, discusses a recent study he led into the cost-effectiveness of polypill and why we do not see the approach applied to cardiovascular disease in the US.

Suraj Kapa, MD, takes part in an episode of DocTalk where he discusses the results of a recent study he led and how to implement technology into cardiology in a way that benefits patients and physicians.

The inaugural episode of the DocTalk Podcast features a conversation about transcatheter aortic valve replacement with two cardiologists from Brigham and Women's Hospital.

A study from investigators at Beth Israel Deaconess Medical Center found that more intense hypertensive treatments did not result in added episodes of orthostatic hypotension.

A study from the AHA's Hypertension Scientific Sessions revealed first- and second-year medical students have a 2.4 higher risk of stage 2 hypertension compared to the general public.

A study of human gut bacteria suggests that high blood pressure with depression may be a completely different disease than high blood pressure without depression.

A Q&A with Brett Carroll, MD, director of Vascular Medicine at Beth Israel Deaconess Medical Center, as he discusses stroke management, DOACs, and warfarin.

A study from the AHA's 2019 Hypertension Scientific Sessions revealed that hypertension was linked to cognitive decline in older patients, but antihypertensive treatment could mitigate this impact.

The DocTalk Podcast, a weekly conversation with leaders and experts in medicine, will launch with 3 new episodes on September 9.

Initial PCSK9 inhibitor plus statin therapy helped hospitalized patients achieve LDL-C

A recent study found that county-level poverty prevalence correlated with both heart failure and coronary heart disease mortality rates.

Naeem Khan, MD, and Kiersten Combs, both of Astrazeneca, discuss how recent news from FDA and ESC Congress 2019 could impact dapagliflozin moving forward.

A recent study presented at ESC Congress 2019 found that a 1 unit increase in BMI at 18 years old translated to a hazard ratio of 1.10.

A recent analysis of more than 400,000 from the UK Biobank revealed those who get more or less than 6 to 9 hours of sleep per day increased their risk of heart attack by more than 20%.

A recent study examining how genetic risk factors and lifestyle choices impact premature coronary artery disease found evidence that various factors play a greater role than genetics for younger patients.

A study presented at ESC Congress 2019 found that anabolic-androgenic steroid use in male weightlifters can lead to thickening of the heart muscle and reduced ejection fraction

Results of the AFIRE study found rivaroxaban monotherapy was noninferior to combination therapy for efficacy and superior to combination therapy for safety.

Investigators find that opening all blockages with stents is more beneficial after a heart attack than targeting just the clogged artery causing the event.

Results of the DAPA-HF study — presented at the ESC Congress 2019, reveal use of dapagliflozin reduce hospitalizations from heart failure and deaths from cardiovascular causes in patients with heart failure with reduced ejection fraction.

Results of the PARAGON HF study, which were presented at ESC Congress 2019, reveal no significant benefit of sacubitril-valsartan compared to valsartan for heart failure with preserved ejection fraction in more than 4,500 patients.

A study presented at ESC Congress 2019 revealed childhood BMI, systolic blood pressure, and serum total cholesterol and triglycerides are positively associated with adult CVD.

An updated list of guidelines recommends using catheter ablation to treat supraventricular tachycardia.

The new cardiology guideline provides step-by-step detail to the currently best process of embolism diagnosis.